DELCATH SYSTEMS INC (DCTH) Fundamental Analysis & Valuation

NASDAQ:DCTH • US24661P8077

9.45 USD
-0.03 (-0.32%)
At close: Mar 13, 2026
9.45 USD
0 (0%)
After Hours: 3/13/2026, 8:20:09 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This DCTH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to DCTH. DCTH was compared to 184 industry peers in the Health Care Equipment & Supplies industry. While DCTH has a great health rating, its profitability is only average at the moment. DCTH is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

4

1. DCTH Profitability Analysis

1.1 Basic Checks

  • In the past year DCTH was profitable.
  • DCTH had a positive operating cash flow in the past year.
  • In the past 5 years DCTH reported 4 times negative net income.
  • In the past 5 years DCTH reported 4 times negative operating cash flow.
DCTH Yearly Net Income VS EBIT VS OCF VS FCFDCTH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M -40M

1.2 Ratios

  • With a decent Return On Assets value of 2.18%, DCTH is doing good in the industry, outperforming 73.91% of the companies in the same industry.
  • The Return On Equity of DCTH (2.43%) is better than 73.91% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 0.45%, DCTH is in the better half of the industry, outperforming 65.76% of the companies in the same industry.
Industry RankSector Rank
ROA 2.18%
ROE 2.43%
ROIC 0.45%
ROA(3y)-51.91%
ROA(5y)-87.52%
ROE(3y)-112.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DCTH Yearly ROA, ROE, ROICDCTH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K -6K

1.3 Margins

  • Looking at the Profit Margin, with a value of 3.17%, DCTH is in the better half of the industry, outperforming 73.91% of the companies in the same industry.
  • Looking at the Operating Margin, with a value of 0.77%, DCTH is in the better half of the industry, outperforming 65.76% of the companies in the same industry.
  • With an excellent Gross Margin value of 86.16%, DCTH belongs to the best of the industry, outperforming 95.65% of the companies in the same industry.
  • In the last couple of years the Gross Margin of DCTH has grown nicely.
Industry RankSector Rank
OM 0.77%
PM (TTM) 3.17%
GM 86.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.9%
GM growth 5Y7.08%
DCTH Yearly Profit, Operating, Gross MarginsDCTH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K -2K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. DCTH Health Analysis

2.1 Basic Checks

  • DCTH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, DCTH has more shares outstanding
  • Compared to 5 years ago, DCTH has more shares outstanding
  • DCTH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DCTH Yearly Shares OutstandingDCTH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
DCTH Yearly Total Debt VS Total AssetsDCTH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • DCTH has an Altman-Z score of 11.70. This indicates that DCTH is financially healthy and has little risk of bankruptcy at the moment.
  • DCTH has a better Altman-Z score (11.70) than 92.93% of its industry peers.
  • There is no outstanding debt for DCTH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 11.7
ROIC/WACC0.04
WACC10.08%
DCTH Yearly LT Debt VS Equity VS FCFDCTH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

2.3 Liquidity

  • DCTH has a Current Ratio of 10.92. This indicates that DCTH is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 10.92, DCTH belongs to the best of the industry, outperforming 94.02% of the companies in the same industry.
  • DCTH has a Quick Ratio of 9.98. This indicates that DCTH is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 9.98, DCTH belongs to the best of the industry, outperforming 94.02% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 10.92
Quick Ratio 9.98
DCTH Yearly Current Assets VS Current LiabilitesDCTH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. DCTH Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 107.14% over the past year.
  • The Revenue has grown by 129.08% in the past year. This is a very strong growth!
  • The Revenue has been growing by 120.10% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)107.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.55%
Revenue 1Y (TTM)129.08%
Revenue growth 3Y215.27%
Revenue growth 5Y120.1%
Sales Q2Q%37.27%

3.2 Future

  • Based on estimates for the next years, DCTH will show a very strong growth in Earnings Per Share. The EPS will grow by 80.28% on average per year.
  • DCTH is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.01% yearly.
EPS Next Y-44.63%
EPS Next 2Y147.39%
EPS Next 3Y123.09%
EPS Next 5Y80.28%
Revenue Next Year27.27%
Revenue Next 2Y28.4%
Revenue Next 3Y25.81%
Revenue Next 5Y22.01%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
DCTH Yearly Revenue VS EstimatesDCTH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M
DCTH Yearly EPS VS EstimatesDCTH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -200M -400M -600M -800M -1B

More info and screens

Find the best growth stocksShow best growing peers

4

4. DCTH Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 135.00, the valuation of DCTH can be described as expensive.
  • Based on the Price/Earnings ratio, DCTH is valued a bit cheaper than 63.59% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.70. DCTH is valued rather expensively when compared to this.
  • With a Price/Forward Earnings ratio of 243.81, DCTH can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of DCTH indicates a somewhat cheap valuation: DCTH is cheaper than 63.59% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.84, DCTH is valued quite expensively.
Industry RankSector Rank
PE 135
Fwd PE 243.81
DCTH Price Earnings VS Forward Price EarningsDCTH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DCTH indicates a somewhat cheap valuation: DCTH is cheaper than 62.50% of the companies listed in the same industry.
  • 94.57% of the companies in the same industry are more expensive than DCTH, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.66
EV/EBITDA 212.49
DCTH Per share dataDCTH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • DCTH's earnings are expected to grow with 123.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y147.39%
EPS Next 3Y123.09%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DCTH Dividend Analysis

5.1 Amount

  • No dividends for DCTH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DCTH Fundamentals: All Metrics, Ratios and Statistics

DELCATH SYSTEMS INC

NASDAQ:DCTH (3/13/2026, 8:20:09 PM)

After market: 9.45 0 (0%)

9.45

-0.03 (-0.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners50.2%
Inst Owner Change-1.74%
Ins Owners2.92%
Ins Owner Change0.99%
Market Cap328.39M
Revenue(TTM)85.23M
Net Income(TTM)2.70M
Analysts84.62
Price Target23.61 (149.84%)
Short Float %11.98%
Short Ratio8.18
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.28%
Min EPS beat(2)-1.96%
Max EPS beat(2)20.51%
EPS beat(4)3
Avg EPS beat(4)72.29%
Min EPS beat(4)-1.96%
Max EPS beat(4)174.51%
EPS beat(8)5
Avg EPS beat(8)-11.78%
EPS beat(12)6
Avg EPS beat(12)-19.4%
EPS beat(16)7
Avg EPS beat(16)-18.06%
Revenue beat(2)0
Avg Revenue beat(2)-1.8%
Min Revenue beat(2)-3.57%
Max Revenue beat(2)-0.02%
Revenue beat(4)2
Avg Revenue beat(4)3.85%
Min Revenue beat(4)-3.57%
Max Revenue beat(4)15.26%
Revenue beat(8)6
Avg Revenue beat(8)14.28%
Revenue beat(12)6
Avg Revenue beat(12)1.9%
Revenue beat(16)9
Avg Revenue beat(16)7.21%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-157.78%
EPS NQ rev (3m)-157.78%
EPS NY rev (1m)-89.68%
EPS NY rev (3m)-89.78%
Revenue NQ rev (1m)-0.64%
Revenue NQ rev (3m)-2.57%
Revenue NY rev (1m)-4.79%
Revenue NY rev (3m)-8.1%
Valuation
Industry RankSector Rank
PE 135
Fwd PE 243.81
P/S 3.85
P/FCF 15.66
P/OCF 14.58
P/B 2.95
P/tB 2.95
EV/EBITDA 212.49
EPS(TTM)0.07
EY0.74%
EPS(NY)0.04
Fwd EY0.41%
FCF(TTM)0.6
FCFY6.39%
OCF(TTM)0.65
OCFY6.86%
SpS2.45
BVpS3.2
TBVpS3.2
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.25
Profitability
Industry RankSector Rank
ROA 2.18%
ROE 2.43%
ROCE 0.59%
ROIC 0.45%
ROICexc 2.35%
ROICexgc 2.35%
OM 0.77%
PM (TTM) 3.17%
GM 86.16%
FCFM 24.6%
ROA(3y)-51.91%
ROA(5y)-87.52%
ROE(3y)-112.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.9%
GM growth 5Y7.08%
F-Score7
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 650%
Cap/Sales 1.82%
Interest Coverage 250
Cash Conversion 2507.35%
Profit Quality 776.63%
Current Ratio 10.92
Quick Ratio 9.98
Altman-Z 11.7
F-Score7
WACC10.08%
ROIC/WACC0.04
Cap/Depr(3y)370.83%
Cap/Depr(5y)273.47%
Cap/Sales(3y)2.04%
Cap/Sales(5y)3.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.55%
EPS Next Y-44.63%
EPS Next 2Y147.39%
EPS Next 3Y123.09%
EPS Next 5Y80.28%
Revenue 1Y (TTM)129.08%
Revenue growth 3Y215.27%
Revenue growth 5Y120.1%
Sales Q2Q%37.27%
Revenue Next Year27.27%
Revenue Next 2Y28.4%
Revenue Next 3Y25.81%
Revenue Next 5Y22.01%
EBIT growth 1Y105.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year913.35%
EBIT Next 3Y331.54%
EBIT Next 5YN/A
FCF growth 1Y208.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y220.53%
OCF growth 3YN/A
OCF growth 5YN/A

DELCATH SYSTEMS INC / DCTH FAQ

What is the ChartMill fundamental rating of DELCATH SYSTEMS INC (DCTH) stock?

ChartMill assigns a fundamental rating of 6 / 10 to DCTH.


Can you provide the valuation status for DELCATH SYSTEMS INC?

ChartMill assigns a valuation rating of 4 / 10 to DELCATH SYSTEMS INC (DCTH). This can be considered as Fairly Valued.


What is the profitability of DCTH stock?

DELCATH SYSTEMS INC (DCTH) has a profitability rating of 4 / 10.


What is the expected EPS growth for DELCATH SYSTEMS INC (DCTH) stock?

The Earnings per Share (EPS) of DELCATH SYSTEMS INC (DCTH) is expected to decline by -44.63% in the next year.